Medibio Limited (MEB:ASX)

Company Overview

Medibio Limited is an Australia-based company engaged in conducting research and development and early-stage commercialization of a diagnostic technology for mental health, which is based on circadian heart rate (CHR) data. The Company completed the development and testing of its Corporate Stress Product, a cloud-based product, including real-time electrocardiogram (ECG) Data Streaming and Algorithm Processing with results back to the Company's application in real time. The Company offers a Corporate Wellness Partner Program. The Company is also engaged in the development of a sleep staging algorithm, which using ECG data only, can distinguish between the stages of sleep. The Company's subsidiaries include Medibio Limited-USA, Invatec Health Pty Ltd and Annapanna Pty Ltd, which are engaged in CHR diagnostic development.